ArticleUrologic oncology2019

Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?

Andrea K Lindner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.